— Know what they know.
Not Investment Advice

CBDD OTC

CBD of Denver, Inc.
1W: +9900.0% 1M: +9900.0% 3M: +0.0% YTD: -33.3% 1Y: -33.3% 3Y: -88.9% 5Y: -98.7%
$0.00
-0.00 (-25.93%)
 
Weekly Expected Move ±9293.7%
$-0 $-0 $0 $0 $0
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 60 · $1.1M mcap · Short 67% of daily vol

Balance Sheet Trends

Total Assets
$41K -68.2% ▼
5Y CAGR: -3.9%
Total Liabilities
$1M -7.0% ▼
5Y CAGR: +16.8%
Shareholders Equity
-$1M +1.1% ▲
Cash & Investments
$35K -3.9% ▼
5Y CAGR: -1.2%
Total Debt
$1M +0.0% ▲
5Y CAGR: +32.4%
Net Debt
$1M +0.1% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$83K$92K$28K$37K$35K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$83K$92K$28K$37K$35K
Net Receivables$2M$2M$0$77K$6K
Inventory$422K$355K$0$3K$0
Other Current Assets$0$0$0$0$0
Total Current Assets$3M$2M$28K$117K$41K
Property, Plant & Equip.$23K$0$0$11K$0
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$52K$0$0$0$0
Other Non-Current Assets$14K$0$0$0$0
Total Non-Current Assets$89K$0$0$11K$0
Total Assets$3M$2M$28K$128K$41K
— Liabilities —
Accounts Payable$1M$731K$962K$297K$121K
Short-Term Debt$253K$263K$0$1M$1M
Deferred Revenue$308K$0$0$5K$0
Other Current Liabilities$18K$208K$86K$115K$193K
Total Current Liabilities$2M$1M$1M$1M$1M
Long-Term Debt$0$519K$949K$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$0$519K$949K$0$0
Total Liabilities$2M$2M$2M$1M$1M
— Equity —
Common Stock$53K$53K$56K$67K$79K
Retained Earnings-$3M-$2M-$5M-$5M-$5M
Accumulated OCI$42K-$88K-$123K-$67K-$67K
Total Stockholders Equity$798K$248K-$2M-$1M-$1M
Total Liabilities & Equity$3M$2M$28K$128K$41K
— Key Metrics —
Total Debt$253K$782K$949K$1M$1M
Net Debt$171K$690K$921K$1M$1M
Total Investments$52K$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms